Turan, Raife Dilek
Albayrak, Esra
Uslu, Merve
Siyah, Pinar
Alyazici, Lamia Yazgi
Kalkan, Batuhan Mert
Aslan, Galip Servet
Yucel, Dogacan
Aksoz, Merve
Tuysuz, Emre Can
Meric, Neslihan
Durdagi, Serdar
Gulbas, Zafer
Kocabas, Fatih
Funding for this research was provided by:
Gilead Sciences (Hematology&Oncology)
Article History
Received: 30 September 2019
Accepted: 20 April 2020
First Online: 14 May 2020
Competing interests
: Dr. Fatih Kocabas is founder of Meinox Pharma Technologies. All other authors declare that they have no conflicts of interest concerning this work.